SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.39p
   
  • Change Today:
    -0.11p
  • 52 Week High: 26.10
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 203,903
  • Market Cap: £42.40m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
98.35% above the market average98.35% above the market average98.35% above the market average98.35% above the market average98.35% above the market average
93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
69.14% above the market average69.14% above the market average69.14% above the market average69.14% above the market average69.14% above the market average
68.00% above the sector average68.00% above the sector average68.00% above the sector average68.00% above the sector average68.00% above the sector average
Price Book Ratio
94.51% below the market average94.51% below the market average94.51% below the market average94.51% below the market average94.51% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
81.2% below the market average81.2% below the market average81.2% below the market average81.2% below the market average81.2% below the market average
56.52% below the sector average56.52% below the sector average56.52% below the sector average56.52% below the sector average56.52% below the sector average
Price Chg 3m
92.5% below the market average92.5% below the market average92.5% below the market average92.5% below the market average92.5% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
64.71% below the market average64.71% below the market average64.71% below the market average64.71% below the market average64.71% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
Momentum 20
67.5% below the market average67.5% below the market average67.5% below the market average67.5% below the market average67.5% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
84.38% below the market average84.38% below the market average84.38% below the market average84.38% below the market average84.38% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
62.85% below the market average62.85% below the market average62.85% below the market average62.85% below the market average62.85% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
78.56% below the market average78.56% below the market average78.56% below the market average78.56% below the market average78.56% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Operating Profit Loss
64.41% below the market average64.41% below the market average64.41% below the market average64.41% below the market average64.41% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
74.9% below the market average74.9% below the market average74.9% below the market average74.9% below the market average74.9% below the market average
58.14% below the sector average58.14% below the sector average58.14% below the sector average58.14% below the sector average58.14% below the sector average
Cash
61.81% below the market average61.81% below the market average61.81% below the market average61.81% below the market average61.81% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 16.39p
Change Today -0.11p
% Change -0.69 %
52 Week High 26.10
52 Week Low 8.50
Volume 203,903
Shares Issued 258.78m
Market Cap £42.40m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.9% below the market average70.9% below the market average70.9% below the market average70.9% below the market average70.9% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Price Trend
42.80% above the market average42.80% above the market average42.80% above the market average42.80% above the market average42.80% above the market average
69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average
Income Not Available
Growth
49.18% above the market average49.18% above the market average49.18% above the market average49.18% above the market average49.18% above the market average
62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average

SBTX Dividends

No dividends found

Trades for 02-Jul-2025

Time Volume / Share Price
16:01 7,224 @ 16.47p
15:51 2,746 @ 16.31p
15:44 4,099 @ 16.31p
15:31 35,000 @ 16.31p
15:22 1,484 @ 16.36p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page